6 completed, 1 unknown. 7 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 6, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
Follow voglibose: new trials by email Literature Review of voglibose trials Research Report on voglibose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM Patients Voglibose + Metformin, Glibenclamide + Metformin - Diabetes Mellitus Type 2 Without Complication | Phase 3 | Unknown | University of Zambia | 118 | 2023-08-01 | 2023-07-03 |
| A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients ipragliflozin, alpha glucosidase inhibitor - Type 2 Diabetes Mellitus | Phase 3 | Completed | Astellas Pharma Inc | 113 | 2010-10-21 | 2025-05-30 |
| MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104) Comparator: Placebo, Sitagliptin, Voglibose - Diabetes Mellitus, Non-Insulin-Dependent | Phase 3 | Completed | Merck Sharp & Dohme LLC | 133 | 2009-02-05 | 2017-05-15 |
| Japanese P III vs Voglibose and Placebo BI 1356, voglibose placebo, BI 1356 placebo - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Boehringer Ingelheim | 561 | 2008-04-01 | 2014-01-27 |
| Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan Alogliptin and voglibose - Type 2 Diabetes Mellitus | Phase 2 / Phase 3 | Completed | Takeda | 179 | 2007-06-01 | 2012-02-03 |
| Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan Alogliptin and voglibose, Voglibose - Type 2 Diabetes Mellitus | Phase 2 / Phase 3 | Completed | Takeda | 230 | 2007-01-01 | 2012-02-03 |
| A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED) sitagliptin phosphate, Comparator: voglibose - Diabetes Mellitus, Non-Insulin-Dependent | Phase 3 | Completed | Merck Sharp & Dohme LLC | 319 | 2007-01-01 | 2016-02-05 |
Diabetes Mellitus, Type 2 (6) · Diabetes Mellitus (3)
Merck Sharp & Dohme LLC (2) · Takeda (2) · Astellas Pharma Inc (1) · Boehringer Ingelheim (1) · University of Zambia (1)
Japan (2)
PMID 22106975, PMID 19732457, PMID 20590736, PMID 22234149, PMID 24843714